tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OCUL Stock Latest News

Ocular Therapeutix Announces New Leadership and Incentive Plan Expansion
Company AnnouncementsOcular Therapeutix Announces New Leadership and Incentive Plan Expansion
7d ago
8K
OCUL
Ocular Therapeutix announces results from Phase 1 data for AXPAXLI
PremiumThe Fly
Ocular Therapeutix announces results from Phase 1 data for AXPAXLI
8d ago
OCUL
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
PremiumPress Releases
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
8d ago
OCUL
Ocular Therapeutix announces appointments of CMO, CDO
PremiumThe Fly
Ocular Therapeutix announces appointments of CMO, CDO
10d ago
OCUL
Ocular Therapeutix appoints Dugel as President, CEO
PremiumThe Fly
Ocular Therapeutix appoints Dugel as President, CEO
11d ago
OCUL
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
PremiumPress ReleasesOcular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
17d ago
OCUL
Ocular Therapeutix reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Ocular Therapeutix reports inducement grants under Nasdaq listing rule
17d ago
OCUL
Ocular Therapeutix announces Phase 2 PAXTRAVA glaucoma data
PremiumThe Fly
Ocular Therapeutix announces Phase 2 PAXTRAVA glaucoma data
19d ago
OCUL
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
PremiumPress Releases
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
19d ago
OCUL
Ocular Therapeutix™ To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)
PremiumPress Releases
Ocular Therapeutix™ To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)
1M ago
OCUL
Ocular Therapeutix files to sell 43.22M shares of common stock for holders
PremiumThe Fly
Ocular Therapeutix files to sell 43.22M shares of common stock for holders
1M ago
OCUL
Ocular Therapeutix price target raised to $15 from $12 at H.C. Wainwright
PremiumThe Fly
Ocular Therapeutix price target raised to $15 from $12 at H.C. Wainwright
1M ago
OCUL
Ocular Therapeutix price target raised to $11 from $8 at TD Cowen
PremiumThe FlyOcular Therapeutix price target raised to $11 from $8 at TD Cowen
1M ago
OCUL
Ocular Therapeutix price target raised to $24 from $12 at JMP Securities
PremiumThe Fly
Ocular Therapeutix price target raised to $24 from $12 at JMP Securities
1M ago
OCUL
Ocular Therapeutix reports Q4 EPS (35c), consensus (30c)
PremiumThe Fly
Ocular Therapeutix reports Q4 EPS (35c), consensus (30c)
2M ago
OCUL
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
PremiumPress Releases
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
2M ago
OCUL
Ocular Therapeutix options imply 11.5% move in share price post-earnings
PremiumThe Fly
Ocular Therapeutix options imply 11.5% move in share price post-earnings
2M ago
OCUL
Options Volatility and Implied Earnings Moves Today, March 11, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 11, 2024
2M ago
EXK
MTN
Ocular Therapeutix™ to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024
PremiumPress Releases
Ocular Therapeutix™ to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024
2M ago
OCUL
Ocular Therapeutix Inc (OCUL) Q4 Earnings Cheat Sheet
PremiumPre-EarningsOcular Therapeutix Inc (OCUL) Q4 Earnings Cheat Sheet
2M ago
OCUL
Ocular Therapeutix options imply 8.8% move in share price post-earnings
PremiumThe Fly
Ocular Therapeutix options imply 8.8% move in share price post-earnings
2M ago
OCUL
Ocular Therapeutix price target raised to $15 from $10 at Piper Sandler
PremiumThe Fly
Ocular Therapeutix price target raised to $15 from $10 at Piper Sandler
2M ago
OCUL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >